Ferraro PM, Taylor EN, Gambaro G, Curhan G
Catalyst for a Cure brings together scientists from different backgrounds to work collaboratively to better understand glaucoma and find ways to improve treatment and ultimately cure this blinding disease
Conclusions and Future Perspectives Overall, GLP-1RAs are considered novel blood glucose lowering drugs used in the treatment of T2MD (229), owing to their advantages of lowering blood pressure, lowering the levels of fasting blood glucose, lowering HbA1c, inducing weight loss, and being associated with a low incidence of hypoglycemia
Apoptosis involves caspase-3-mediated protein degradation without inflammation [148]
In laboratory settings, BPC-157 is analyzed for its role in angiogenic signaling and the maintenance of epithelial barrier stability